Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Pfizer and Roivant launch autoimmune specialist Priovant

US panel backs Omicron-targeting vaccines for booster campaigns

Pharma’s post-pandemic launch performance problem: what’s the prognosis?

NHS App could offer video consultations by 2024

Novartis will shed 7% of workforce in restructuring, say reports

Libmeldy

DNA Concept

Market Access/ News/ News

NHS signs deal with Orchard for pricey Libmeldy gene therapy

Phil Taylor gene therapy, HEOR, Libmeldy, NHS, NICE, Orchard Therapeutics, paediatric, rare disease 0 Comment

NHS England has agreed a confidential deal with Orchard Therapeutics that will allow access to Libmeldy – a

X

NHS signs deal with Orchard for pricey Libmeldy gene therapy

https://pharmaphorum.com/news/nhs-signs-deal-with-orchard-for-pricey-libmeldy-gene-therapy/

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Market Access/ News/ News

NICE rejects Orchard’s gene therapy for rare childhood disease MLD

Phil Taylor gene therapy, HEOR, Libmeldy, NICE, Orchard Therapeutics, paediatric, rare disease 0 Comment

Orchard Therapeutics’ gene therapy for rare childhood disease metachromatic leukodystrophy (MLD) Libmeldy has been rejected for NHS use

X

NICE rejects Orchard’s gene therapy for rare childhood disease MLD

https://pharmaphorum.com/news/nice-rejects-orchards-gene-therapy-for-rare-childhood-disease-mld/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Ipsen beefs up in oncology, buying US biopharma Epizyme
GSK hepatitis B hope bepirovirsen heads for phase 3 test
Novartis will shed 7% of workforce in restructuring, say reports
Another Astellas gene therapy hits a safety hurdle
BioMarin gene therapy for haemophilia on course for EU approval

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com